The present invention relates to a fumarate
metal-organic framework for treating ocular bacterial infections, and also relates to its use in treating ocular bacterial infections. The fumarate
metal-organic framework is Zr / Fe@FA MOFs, the
metal coordination ions are Zr(IV) and Fe(III), and the ligand is
fumaric acid. The Zr / Fe@FA MOFs have excellent anti-
biofilm activity, and their effect can be greatly improved when used in combination with
levofloxacin. In addition, the present invention also provides an encapsulated microneedle
system, Zr / Fe@FA MNs, which can deliver MOFs directly to bacterial microcolony
lesion areas in 3D confined microenvironments through the precise penetration ability of microneedles, significantly enhancing the effectiveness of drugs in
biofilm eradication. Zr / Fe@FA MNs can not only overcome the limitations of traditional eye drops in corneal permeability, but also achieve long-term treatment through the sustained release of MOFs and the slow-release properties of microneedles.